Aptinyx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Aptinyx and buy or sell other stocks, ETFs, and their options commission-free!About APTX
Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees—
Employees—
HeadquartersEvanston, Illinois
HeadquartersEvanston, Illinois
Founded2015
Founded2015
Employees—
Employees—
APTX Key Statistics
Market cap6.50M
Market cap6.50M
Price-Earnings ratio-0.10
Price-Earnings ratio-0.10
Dividend yield—
Dividend yield—
Average volume536.11K
Average volume536.11K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.72
52 Week high$0.72
52 Week low$0.009
52 Week low$0.009
Stock Snapshot
As of today, Aptinyx(APTX) shares are valued at $0.10. The company's market cap stands at 6.5M, with a P/E ratio of -0.10.
During the trading day, Aptinyx(APTX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 536.11K.
The stock's 52-week range extends from a low of $0.01 to a high of $0.72.
The stock's 52-week range extends from a low of $0.01 to a high of $0.72.
People also own
Based on the portfolios of people who own APTX. This list is generated using Robinhood data, and it’s not a recommendation.